US Patent 8686155 Aurora kinase modulators and method of use
Patent 8686155 was granted and assigned to Amgen on April, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 14 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 Dec, 2023
Golden AI
Edits made to:
Article (+93 characters)
Article
Patent abstract
The present invention relates to chemical compounds having a general formula I
Edits on 25 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Laurie Schenkel0
Philip R. Olivieri0
Victor J. Cee0
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08686155 Aurora kinase modulators and method of use US Patent 8686155 Aurora kinase modulators and method of use
Infobox
Patent Number
086861550
Patent Number
86861550
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
086861550
Date of Patent
April 1, 2014
0Patent Application Number
131713550
Date Filed
June 28, 2011
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08686155 Aurora kinase modulators and method of use
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08686155
Date of patent
April 1, 2014
Patent application number
13171355
Date Filed
June 28, 2011
Patent primary examiner
Find more entities like US Patent 8686155 Aurora kinase modulators and method of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.